Samsung Medical Center
| Republik Korea | Türkei | Österreich | |
| Gamma-Messer | von $13,500 | von $6,300 | von $32,000 |
| Chemotherapie bei Brustkrebs | von $19,200 | von $1,200 | von $15,000 |
| Strahlentherapie bei Sarkomen | - | von $3,250 | von $18,000 |
| Strahlentherapie bei Darmkrebs | - | von $7,000 | von $12,000 |
Bookimed erhebt keine zusätzlichen Gebühren für Osteosarkom-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Osteosarkom einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Osteosarkom-Behandlungsreise nie allein.
Top South Korean hospitals for osteosarcoma include Asan Medical Center, Severance Hospital, and Samsung Medical Center. These centers provide JCI-accredited care. They offer multidisciplinary treatment involving orthopedic oncology, heavy ion therapy, and limb-sparing surgery. Most facilitate complex reconstructions in specialized sarcoma units.
Bookimed Expert Insight: While many global patients search for general oncology, South Korea's strength lies in high-volume tertiary centers. Samsung Medical Center and Asan Medical Center together treat over 2,000,000 patients annually. This massive scale ensures surgeons maintain high proficiency in rare cases like bone sarcoma. We recommend choosing Seoul-based university hospitals because they integrate pathology and limb reconstruction in one location.
Patient Consensus: Patients emphasize the importance of going directly to a major academic center in Seoul. They notes that having a dedicated orthopedic oncology team for limb-sparing reconstruction is a priority.
Osteosarcoma treatment in Korea primarily uses a multidisciplinary approach combining limb-salvage surgery, neoadjuvant chemotherapy, and advanced radiation. Leading Seoul-based centers specialize in organ-preserving techniques. These facilities utilize Joint Commission International-accredited protocols to maximize joint function and achieve high survival rates for pediatric and adult patients.
Bookimed Expert Insight: Korea's infrastructure for bone cancer is concentrated in massive digitalized hubs. Seoul National University Hospital and Severance Hospital manage over 1,500,000 patients annually. This high volume allows orthopedic oncology teams to specialize in rare procedures like robotic-assisted reconstructions. Patients benefit from this specialized experience which is often unavailable in smaller regional hospitals.
Patient Consensus: Patients prioritize finding surgeons experienced in limb-sparing techniques to ensure the best mobility after recovery. They emphasize the importance of early rehabilitation to regain limb function following long chemotherapy cycles.
In South Korea, patients typically receive a definitive medical diagnosis within 1 to 7 days. Critical tests like CT scans are finalized within 48 hours. Many Seoul-based hospitals provide MRI results on the same day. Comprehensive oncology evaluations for complex cases like osteosarcoma are usually completed within 1 week.
Bookimed Expert Insight: Data shows that tertiary centers in Seoul like Asan Medical Center manage over 11,000 outpatients daily. This massive volume drives efficiency. While general orthopedics might have wait times, choosing a center with a dedicated orthopedic oncology department can significantly compress the diagnostic timeline. These institutions use integrated digital systems to share pathology and imaging results between departments instantly.
Patient Consensus: Patients note that diagnosis speeds up once cancer is suspected. It is vital to bring all previous scans to avoid repeating basic imaging steps.
South Korea hosts highly specialized orthopedic oncologists at JCI-accredited centers in Seoul. Experts like Dr. Myung-Chul Lee at Seoul National University Hospital (SNUH) lead multidisciplinary teams. These specialists focus on bone cancer, providing advanced limb-salvage surgeries and complex reconstructions for international patients.
Bookimed Expert Insight: Patient volume is a reliable proxy for expertise in Korea. Hospitals like Severance serve 1.6 million outpatients annually. This massive scale allows surgeons to specialize intensely in rare conditions like osteosarcoma. Choosing these high-volume facilities ensures access to specialists who focus exclusively on bone tumors.
Patient Consensus: Patients emphasize the need to seek orthopedic oncologists rather than general orthopedists. They note that biopsy technique in Seoul centers significantly affects long-term surgical outcomes.
South Korean oncology centers utilize high-resolution imaging to stage osteosarcoma and plan limb-sparing surgeries. Diagnostic protocols typically include MRI for local tumor assessment and chest CT to monitor for lung metastasis. Hybrid PET/CT and scintigraphy identify distant skeletal lesions within JCI-accredited facilities.
Bookimed Expert Insight: Major Korean hospitals like Asan Medical Center and Samsung Medical Center maintain massive surgical volumes, performing over 45,000 to 65,000 operations annually. This high throughput allows for highly protocol-driven imaging workflows where results are integrated into digital systems like the BESTcare system at SNUBH for immediate surgical planning.
Patient Consensus: Patients note that major hospitals move very quickly with imaging once symptoms appear. Many emphasize keeping digital copies of all scans to facilitate smoother second opinions during their treatment journey.